Device Trial Radar · NCT03201432
Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis
Last checked: Nov 20, 2026Latest source record: Jun 28, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
160
Actual
Start
May 2014
Primary completion
Jan 2017
Study completion Jan 2017
Sponsor
- Lead sponsor
- Xiongjing JiangAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Yinyi(Liaoning) Biotech Co., Ltd.
- First posted
- Jun 28, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Stroke is one of the important causes of disability and death in the world, in which more than half were ischemic strokes. About 1/4 of the ischemic stroke occurred in the vertebral basilar artery system, especially when in the presence of extracranial proximal vertebral artery stenosis. Vertebral artery stenting is a minimally invasive method for the reconstruction of vertebral artery stenosis and the early clinical studies showed that it was feasible, safe and effective, but the high rate of restenosis has become a bottleneck restricting its development. Previous systematic review had suggested that the drug eluting stent might reduce the incidence of restenosis of vertebral artery. However, prospective randomized controlled trials comparing the efficacy of bare metal stents and drug eluting stents on the prevention of restenosis remains absent.
Conditions
- Ischemic Stroke
- Vertebral Artery Stenosis
Interventions
Drug eluting stent (DES)Device
Polymer-free paclitaxel eluting stents
Bare metal stent (BES)Device
Bare metal stent
Primary outcomes
What the sponsor says the trial is designed to measure.
- Stent restenosis rate 6 months after stentingTime frame: 6 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.